Vitamin B7 May Halt Cancer Cell Growth

Blocking the Metabolic Switch

Researchers at the University of Lausanne discovered a potential new way to fight cancer. Their work, released April 20, 2026, focuses on how cancer cells utilize nutrients. The findings suggest vitamin B7 could disrupt cancer metabolism.

Cancer cells rapidly divide and need a constant energy supply. They often rely heavily on glutamine, an amino acid. However, some cancer cells adapt and find alternative fuel sources to survive. This adaptability makes treatment difficult. Scientists sought to understand how to block this metabolic flexibility.

The research team found vitamin B7, also known as biotin, plays a crucial role. It acts as a „metabolic license” for cancer cells. Specifically, B7 is required for cells to switch from using glutamine to alternative fuels. Without sufficient B7, these cells struggle to adapt when glutamine is limited. This effectively traps them, hindering their growth and spread.

Can This Become a New Therapy?

„We observed that cancer cells become incredibly reliant on this vitamin to change their metabolic pathways,” explained a lead researcher. „By restricting B7, we can prevent them from becoming resistant to therapies targeting glutamine.” The team conducted experiments on various cancer cell lines. Results showed a significant reduction in growth when B7 was limited.

The study isn’t about simply adding more B7 to a patient’s diet. It’s about strategically *removing* it. Researchers are exploring ways to develop drugs that block the cellular uptake or utilization of vitamin B7. This could make existing cancer treatments more effective. It might also offer a new approach for cancers resistant to current therapies.

Frequently Asked Questions

The next steps involve testing these findings in animal models. If successful, clinical trials in humans would be necessary. While still early, this research offers a promising new avenue for cancer treatment. It highlights the importance of understanding cancer’s complex metabolic needs.

Could a B7 deficiency actually *cause* cancer? No, a deficiency is unlikely to cause cancer. The research focuses on exploiting the cancer cells’ *need* for B7, not creating a deficiency. The goal is to disrupt their metabolism, not induce a nutritional imbalance in healthy cells.

What types of cancer responded best in the study? The research indicated broad effectiveness across several cancer types. However, cells exhibiting a strong ability to switch from glutamine to other fuels showed the most dramatic response to B7 restriction. This suggests it may be particularly effective against aggressive, adaptable cancers.